Background: The HeartMate II (Thoratec Corp, Pleasanton, CA) continuous-flow left ventricular assist device (LVAD) improved survival in destination therapy (DT) patients during a randomized trial compared with pulsatile-flow LVADs. This study documented changes in cognitive performance in DT patients from that trial to determine if there were differences between continuous-flow and pulsatile-flow support.
Methods: Data were collected in a sub-study from 96 HeartMate II continuous-flow and 30 HeartMate XVE pulsatile-flow LVAD patients from 12 of the 35 trial sites that followed the same serial neurocognitive (NC) testing protocol at 1, 3, 6, 12, and 24 months after LVAD implantation. Spatial perception, memory, language, executive functions, and processing speed were the domains assessed with 10 standard cognitive measures. Differences over time and between LVAD type were evaluated with linear mixed-effects modeling.
Results: From 1 to 24 months after LVAD implantation, changes in NC functions were stable or showed improvement in all domains, and there were no differences between the continuous-flow and pulsatile-flow groups. Data at 24 months were only available from patients with the continuous-flow LVAD due to the limited durability of the HeartMate XVE device. There was no decline in any NC domain over the time of LVAD support. Missing data not collected from patients who died could have resulted in a bias toward inflated study results.
Conclusions: The NC performance of advanced heart failure patients supported with continuous-flow and pulsatile-flow LVADs shows stabilization or improvement during support for up to 24 months.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.healun.2011.10.012 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
In Vitro Analysis of Left Ventricular Assist Device Outflow Graft Orientations and Their Effect on Aortic Hemodynamics.
ASAIO J
December 2024
From the Department of Cardiac Surgery, LMU University Hospital, Ludwig Maximilian University Munich, Munich, Germany.
Continuous-flow left ventricular assist devices have become an important treatment option for patients with advanced heart failure. However, adverse hemodynamic effects as consequence of an altered blood flow within the aorta and the aortic root remain a topic of concern. In this work, we investigated the influence of the outflow graft orientation on the hemodynamic profile and flow parameters within the thoracic aorta.
View Article and Find Full Text PDFVascular function in patients with advanced heart failure and continuous-flow or pulsatile ventricular assist devices.
Clin Res Cardiol
August 2024
Department of Cardiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Article Synopsis
- A significant number of heart failure patients progress to advanced stages, which heightens health risks, and some may qualify for advanced treatments like ventricular assist devices (VAD).
- This study assessed vascular function in 34 patients with VAD compared to 34 patients with advanced heart failure, finding that those with VAD showed improved endothelial function in larger arteries but not in microcirculation.
- The findings suggest that while VAD implantation benefits endothelial function at the arterial level, it does not enhance microvascular function in advanced heart failure patients.
Model of Arteriovenous Malformation Created in Human Placenta for Training in Vascular Microneurosurgery.
Oper Neurosurg (Hagerstown)
July 2024
Department of Neurology and Neurosurgery, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Article Synopsis
- Arteriovenous malformations (AVMs) are complex congenital lesions requiring advanced surgical skills, and human placentas offer a realistic training model for AVM surgery.
- The study involved creating AVM-type lesions in 15 human placentas using synthetic materials, allowing neurosurgeons to practice microsurgical techniques in a controlled environment.
- Results showed that this model effectively simulates the key characteristics of AVMs, making it a valuable tool for training in vascular microsurgery.
Improving Mechanical Circulatory Support Outcomes in Failing Bidirectional Glenn Physiology.
Pediatr Cardiol
July 2024
Departments of Cardiology and Pediatrics, Boston Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02115, USA.
There remains high morbidity and mortality with mechanical circulatory support (MCS) in failing bidirectional Glenn (BDG) physiology. We performed a retrospective analysis of children with BDG physiology supported with MCS before and after 2018. Fourteen patients met inclusion criteria (median age 1.
View Article and Find Full Text PDFDevelopment of microfluidic models to study endothelial responses to pulsatility with different mechanical circulatory support devices.
Analyst
June 2024
School of Biomedical Engineering, Faculty of Medicine, Dalian University of Technology, Dalian 116024, Liaoning Province, P. R. China.
Continuous-flow ventricular assist devices (CFVAD) and counterpulsation devices (CPD) are used to treat heart failure (HF). CFVAD can diminish pulsatility, but pulsatile modes have been implemented to increase vascular pulsatility. The effects of CFVAD in a pulsatile mode and CPD support on the function of endothelial cells (ECs) are yet to be investigated.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!